COVID-19 

The PMCPA is following government guidance regarding COVID-19, therefore staff are working from home until further notice. No meetings will take place in the offices but, where appropriate, may be held online or by phone. Staff continue to be contactable via email or phone. 

Training

The PMCPA has cancelled the Seminar previously scheduled for June 2020 and further dates are subject to change following government guidance around COVID-19. For more information please see the Training section. 

ABPI Exam

Following government guidance around COVID-19 the ABPI is reviewing the staging of its examinations for Medical Representatives. For more information see the ABPI exams webpage. 

To extend the time available to take the examination an application should be made on the form on the training section of this website. The request should preferably be made by the company rather than a representative. 

 

The Prescription Medicines Code of Practice Authority Welcome

The Prescription Medicines Code of Practice Authority (PMCPA) is the self-regulatory body which administers the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry, independently of the ABPI.  It was established by the ABPI on 1 January 1993.

The Authority is responsible for the provision of advice, guidance and training on the Code as well as for the complaints procedure.  It is also responsible for arranging for conciliation between companies when requested to do so and for arranging for the scrutiny of advertising and meetings on a regular basis.

 

TRAINING 

Code of Practice Seminars 

- dates under review. Due to government guidance on COVID-19 the PMCPA has cancelled the Seminar previously scheduled for June 2020 and further dates are subject to change.

ABPI Examination for Medical Representatives

postponed due to COVID-19. More information is available on the ABPI website, link below

https://exams.abpi.org.uk/Pages/home.aspx

To extend the time available to take the examination and application for an extension should be made on the form on this website, link below  

https://www.pmcpa.org.uk/training/application-for-an-extension-of-time-to-take-the-representative-examinations/

The request should preferably be made by the company rather than the representative. 

In house training 

- under review due to COVID-19

eLearning Module 

- unavailable until after the next version of the ABPI Code has been agreed and implemented

For more information see Training Opportunities. 

https://www.pmcpa.org.uk/training/

Media

  • COVID-19 Updates on PMCPA staffing, Seminars and Examination extensions.

    18 March 2020

    read more
  • Daiichi-Sankyo, GW Pharmaceuticals, Bayer plc, Proveca Ltd, Otsuka UK and Otsuka Europe named in advertisements for breaches of the ABPI Code of Practice

    27 July 2019

    read more